Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://texasobserver.social/users/oconnell/statuses/111676940321471331">Kit O'Connell 🏳️‍⚧️ (oconnell@texasobserver.social)'s status on Monday, 01-Jan-2024 07:14:14 JST</a><a href="https://texasobserver.social/@oconnell" title="oconnell@texasobserver.social"><img src="https://gnusocial.jp/avatar/99103-48-20231113185819.webp" width="48" height="48" alt="Kit O'Connell 🏳️‍⚧️" style="position: absolute; left: 0; top: 0;">Kit O'Connell 🏳️‍⚧️</a><div><a href="https://texasobserver.social/@oconnell/111676824637608932" rel="in-reply-to">in reply to</a><ul><li></ul></div></section><article><p>This summer, I traveled on behalf of <a href="https://texasobserver.social/@TexasObserver">@TexasObserver</a> to New York for the GLAAD <a href="https://texasobserver.social/tags/Media" rel="tag">#Media</a> Awards, after my 2022 article on <a href="https://texasobserver.social/tags/transphobia" rel="tag">#transphobia</a> in the <a href="https://texasobserver.social/tags/NYTimes" rel="tag">#NYTimes</a> got nominated. It's my first nomination for any kind of award, so I'm quite proud of my work~! <a href="https://www.texasobserver.org/emily-bazelon-transgender-healthcare-debate-new-york-times?utm_campaign=mastodon" rel="nofollow noreferrer">https://www.texasobserver.org/emily-bazelon-transgender-healthcare-debate-new-york-times?utm_campaign=mastodon</a></p><p><a href="https://texasobserver.social/tags/journalism" rel="tag">#journalism</a> <a href="https://texasobserver.social/tags/LGBTQIA" rel="tag">#LGBTQIA</a>+ <a href="https://texasobserver.social/tags/gender" rel="tag">#gender</a> <a href="https://texasobserver.social/tags/healthcare" rel="tag">#healthcare</a> <a href="https://texasobserver.social/tags/children" rel="tag">#children</a> <a href="https://texasobserver.social/tags/trans" rel="tag">#trans</a> <a href="https://texasobserver.social/tags/BestOf2023" rel="tag">#BestOf2023</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/2524075#notice-4996538">In conversation</a><time datetime="2024-01-01T07:14:14+09:00" title="Monday, 01-Jan-2024 07:14:14 JST">about 10 months ago</time> <span>from <span><a href="https://texasobserver.social/@oconnell/111676940321471331" rel="external" title="Sent from texasobserver.social via ActivityPub">texasobserver.social</a></span></span><a href="https://texasobserver.social/@oconnell/111676940321471331">permalink</a><h4>Attachments</h4><ol><li><article><header><div>Domain not in remote thumbnail source whitelist: www.texasobserver.org</div><h5><a href="https://www.texasobserver.org/emily-bazelon-transgender-healthcare-debate-new-york-times/">There Is No Legitimate ‘Debate’ Over Gender-Affirming Healthcare</a></h5><div> from <span>@TexasObserver</span></div></header><div>A recent New York Times article that experts called inaccurate and unethical now serves as evidence in Texas against transgender kids.</div><footer></footer></article></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
Kit O'Connell 🏳️‍⚧️ (oconnell@texasobserver.social)'s status on Monday, 01-Jan-2024 07:14:14 JSTKit O'Connell 🏳️‍⚧️
in reply to
- Texas Observer
This summer, I traveled on behalf of @TexasObserver to New York for the GLAAD #Media Awards, after my 2022 article on #transphobia in the #NYTimes got nominated. It's my first nomination for any kind of award, so I'm quite proud of my work~! https://www.texasobserver.org/emily-bazelon-transgender-healthcare-debate-new-york-times?utm_campaign=mastodon
#journalism #LGBTQIA+ #gender #healthcare #children #trans #BestOf2023
In conversationabout 10 months ago from texasobserver.socialpermalink
Attachments
1. Domain not in remote thumbnail source whitelist: www.texasobserver.org
  There Is No Legitimate ‘Debate’ Over Gender-Affirming Healthcare
  from @TexasObserver
  A recent New York Times article that experts called inaccurate and unethical now serves as evidence in Texas against transgender kids.

Public

Embed Notice

HTML Code

Corresponding Notice